Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Guangrun Technology is a specialized manufacturer and supplier of pharmaceutical intermediates and fine chemicals based in Shijiazhuang, China. The company focuses on the research, development, and production of organic compounds that serve as essential building blocks for the synthesis of active pharmaceutical ingredients (APIs). Their product portfolio includes a variety of heterocyclic compounds, reagents, and custom-synthesized molecules tailored for the global life sciences and pharmaceutical sectors. By providing high-quality chemical precursors, Hebei Guangrun Technology supports the drug development pipelines of biotechnology firms and pharmaceutical manufacturers worldwide. The company operates with a focus on technical innovation and quality assurance to meet international standards for chemical production. Their services include custom synthesis, process optimization, and large-scale manufacturing to accommodate various stages of drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Guangrun Technology.